跳至主要内容
临床试验/CTRI/2026/01/101901
CTRI/2026/01/101901尚未招募3 期

A comparative study to assess the effectiveness of individualised homoeopathic medicines with standard line of treatment in the improvement of disease activity score in management of rheumatoid arthritis: a randomized controlled trial

Dr Preeti Lamba2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年2月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
200
试验地点
2
主要终点
To assess the extent of reduction in joint pain, swelling and stiffness measured by the Disease Activity Score (DAS28) in Rheumatoid Arthritis patients

研究概览

简要总结

Rheumatoid arthritis (RA) can make daily living difficult since it limits mobility and damages joints. RA reduces a person’s quality of life since it incapacitates them. There is no known treatment for RA, although there are medications that may be able to control symptoms and slow the disease’s progression. Previous research has suggested that homoeopathy may improve patient outcomes in chronic diseases, but rigorous clinical trials comparing its efficacy to standard treatment in RA are missing. This research may also lessen the dependence on larger doses of traditional medications, hence minimizing associated negative effects.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
30.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Participants must be diagnosed with rheumatoid arthritis according to recognised diagnostic standards set by American College of Rheumatology/European League Against Rheumatism Both male and female
  • Age 30 to 50 years
  • Disease Activity Score 28 between 2.6 to 5.1.

排除标准

  • Age less than 30 and above 50 years
  • Disease Activity Score 28 less than 2.6 and more than 5.1
  • Any bone deformity
  • Pregnant or lactating women.

结局指标

主要结局

To assess the extent of reduction in joint pain, swelling and stiffness measured by the Disease Activity Score (DAS28) in Rheumatoid Arthritis patients

时间窗: Every three months

次要结局

  • To assess improvement in health-related quality of life measured by the Health Assessment Questionnaire in Rheumatoid Arthritis patients(Every three months)
  • To measure the improvement or changes if any in necessary investigations performed at the beginning and end of study especially C- Reactive Protein (CRP) & Erythrocyte Sedimentation Rate (ESR)(Every three months)

研究者

发起方
Dr Preeti Lamba
申办方类型
Other [It is self sponsored project with no external funding]
责任方
Principal Investigator
主要研究者

Dr Preeti Lamba

Dr D Y Patil Homoeopathic Medical College and Research Centre Pimpri Pune

研究点 (2)

Loading locations...

相似试验